313 related articles for article (PubMed ID: 22981677)
1. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
Aizawa N; Homma Y; Igawa Y
Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.
Aizawa N; Homma Y; Igawa Y
Neurourol Urodyn; 2015 Apr; 34(4):368-74. PubMed ID: 24532414
[TBL] [Abstract][Full Text] [Related]
3. Functional roles of bladder α1-adrenoceptors in the activation of single-unit primary bladder afferent activity in rats.
Aizawa N; Sugiyama R; Ichihara K; Fujimura T; Fukuhara H; Homma Y; Igawa Y
BJU Int; 2016 Jun; 117(6):993-1001. PubMed ID: 26332379
[TBL] [Abstract][Full Text] [Related]
4. The role of transient receptor potential ankyrin 1 (TRPA1) channel in activation of single unit mechanosensitive bladder afferent activities in the rat.
Minagawa T; Aizawa N; Igawa Y; Wyndaele JJ
Neurourol Urodyn; 2014 Jun; 33(5):544-9. PubMed ID: 23784920
[TBL] [Abstract][Full Text] [Related]
5. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics.
De Laet K; De Wachter S; Wyndaele JJ
Neurourol Urodyn; 2006; 25(2):156-61. PubMed ID: 16372316
[TBL] [Abstract][Full Text] [Related]
6. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.
Aizawa N; Ito H; Sugiyama R; Fujimura T; Suzuki M; Fukuhara H; Homma Y; Igawa Y
J Urol; 2015 Apr; 193(4):1423-32. PubMed ID: 25219701
[TBL] [Abstract][Full Text] [Related]
8. Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.
Iijima K; De Wachter S; Wyndaele JJ
Eur Urol; 2007 Sep; 52(3):842-7. PubMed ID: 17360104
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of phosphodiesterase 5 inhibitor, tadalafil, on mechanosensitive bladder afferent nerve activities of the rat, and on acrolein-induced hyperactivity of these nerves.
Minagawa T; Aizawa N; Igawa Y; Wyndaele JJ
BJU Int; 2012 Sep; 110(6 Pt B):E259-66. PubMed ID: 22591258
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction.
Aizawa N; Watanabe D; Fukuhara H; Fujimura T; Kume H; Homma Y; Igawa Y
Neurourol Urodyn; 2018 Aug; 37(6):1897-1903. PubMed ID: 29508437
[TBL] [Abstract][Full Text] [Related]
11. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
De Wachter S; Wyndaele JJ
J Urol; 2003 May; 169(5):1892-5. PubMed ID: 12686868
[TBL] [Abstract][Full Text] [Related]
12. Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Hatanaka T; Ukai M; Watanabe M; Someya A; Ohtake A; Suzuki M; Ueshima K; Sato S; Kaku S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):71-8. PubMed ID: 23224420
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.
Sawada N; Nomiya M; Hood B; Koslov D; Zarifpour M; Andersson KE
Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.
Aizawa N; Ichihara K; Fukuhara H; Fujimura T; Andersson KE; Homma Y; Igawa Y
Sci Rep; 2017 Aug; 7(1):7646. PubMed ID: 28794457
[TBL] [Abstract][Full Text] [Related]
15. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
[TBL] [Abstract][Full Text] [Related]
16. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat.
Aizawa N; Wyndaele JJ; Homma Y; Igawa Y
Neurourol Urodyn; 2012 Jan; 31(1):148-55. PubMed ID: 22038643
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of pelvic organ cross-talk: 2. Impact of colorectal distention on afferent nerve activity of the rat bladder.
Minagawa T; Wyndaele M; Aizawa N; Igawa Y; Wyndaele JJ
J Urol; 2013 Sep; 190(3):1123-30. PubMed ID: 23542407
[TBL] [Abstract][Full Text] [Related]
18. Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder.
Aizawa N; Ito H; Sugiyama R; Fujimura T; Fukuhara H; Kume H; Homma Y; Igawa Y
Low Urin Tract Symptoms; 2017 Jan; 9(1):57-61. PubMed ID: 28120447
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of vibegron, a β
Aizawa N; Fujita T
Eur J Pharmacol; 2022 Oct; 933():175272. PubMed ID: 36108733
[TBL] [Abstract][Full Text] [Related]
20. The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity.
Svalø J; Nordling J; Bouchelouche K; Andersson KE; Korstanje C; Bouchelouche P
Eur J Pharmacol; 2013 Jan; 699(1-3):101-5. PubMed ID: 23246623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
